Jiangsu CoWin Biotech Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-137.72	-157.21	-84.41	159.26	125.85	108.16
Depreciation & Amortization	38.83	38.83	33.55	23.25	15.73	4.6
Other Amortization	4.33	4.33	3.69	3.06	2.31	1.66
Loss (Gain) From Sale of Assets	-0.19	-0.19	-1.24	0.51	-1.29	-
Asset Writedown & Restructuring Costs	3.44	3.44	4.27	0.06	0.03	0.03
Loss (Gain) From Sale of Investments	-18.21	-18.21	-26.71	-7.94	-7.57	-3.27
Provision & Write-off of Bad Debts	21.67	21.67	20.8	9.51	1.6	0.77
Other Operating Activities	5.34	3.83	8.94	16.85	3.13	0.14
Change in Accounts Receivable	-11.84	-11.84	52.74	-97.15	-16.08	-19.67
Change in Inventory	-19.48	-19.48	17.55	-23.29	-9.6	-6.07
Change in Accounts Payable	21.91	21.91	-43.75	14.18	20.47	17.83
Change in Other Net Operating Assets	2.9	2.9	16.33	13.15	8.43	2.59
Operating Cash Flow	-92.26	-113.26	-11.72	107.37	144.5	108.89
Operating Cash Flow Growth	-	-	-	-25.70%	32.70%	4570.17%
Capital Expenditures	-36.28	-48.41	-159.22	-100.38	-124.39	-13.46
Sale of Property, Plant & Equipment	0.37	0.2	1.01	0.01	0.08	-
Cash Acquisitions	-13.83	-13.83	-	-5.21	-	-
Investment in Securities	47.36	121.31	-479	-165	68.6	-302.95
Other Investing Activities	17.69	14.89	16.29	6.77	8.71	1.8
Investing Cash Flow	15.31	74.16	-620.91	-263.81	-47	-314.6
Long-Term Debt Issued	-	6	-	-	-	52.01
Long-Term Debt Repaid	-	-14.4	-7.57	-5.31	-4.54	-52.01
Net Debt Issued (Repaid)	-4.4	-8.4	-7.57	-5.31	-4.54	-
Issuance of Common Stock	-	3.06	-	1,083	-	275
Repurchase of Common Stock	-43.66	-43.66	-	-	-	-
Common Dividends Paid	-4.09	-3.9	-50.73	-	-	-32.58
Other Financing Activities	40.31	-	6	-19.27	-3.22	-0.91
Financing Cash Flow	-11.83	-52.9	-52.3	1,058	-7.76	241.52
Foreign Exchange Rate Adjustments	0.17	0.21	0.64	1.79	-0.77	-0.9
Net Cash Flow	-88.61	-91.79	-684.29	903.72	88.98	34.91
Free Cash Flow	-128.54	-161.67	-170.94	6.99	20.11	95.44
Free Cash Flow Growth	-	-	-	-65.25%	-78.93%	-
Free Cash Flow Margin	-76.89%	-128.44%	-99.77%	1.34%	5.94%	40.92%
Free Cash Flow Per Share	-1.16	-1.45	-1.52	0.07	0.24	1.36
Cash Income Tax Paid	3.99	5.66	23.45	36.72	17.62	20.34
Levered Free Cash Flow	-320.01	-127.04	-115.19	-38.17	-9.99	56.26
Unlevered Free Cash Flow	-319.33	-126.16	-114.13	-36.96	-8.79	56.33
Change in Working Capital	-9.75	-9.75	29.39	-97.19	4.71	-3.19

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.